Stay updated with breaking news from Avisa Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Urea Breath Test Market, by Test Type, by Product, by Instrument, by End-user, and by Region" report has been added to...
Epygenix Therapeutics appointed G. Michael Landis as chief financial officer, the Paramus biopharmaceutical company announced March 23.
Avisa Diagnostics Retains Venture Liquidity Providers Inc. for Market-Making Services Avisa Diagnostics Inc. a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load in Post-COVID-19 long haulers and for ventilator-associated pneumonia, is pleased to announce that the Company has, subject to regulatory approval, retained Venture Liquidity Providers Inc. to initiate market-making services to provide … Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an...